Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucositis × Daunorubicin × Clear all

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1

Conditions

Leukemia, Myeloid, Acute 136 Leukemia 84 Precursor Cell Lymphoblastic Leukemia-Lymphoma 75 Leukemia, Monocytic, Acute 26 Leukemia, Myelomonocytic, Acute 24 Leukemia, Erythroblastic, Acute 22 Leukemia, Megakaryoblastic, Acute 20 Congenital Abnormalities 18 Burkitt Lymphoma 18 Myelodysplastic Syndromes 15 Lymphoma 14 Myeloproliferative Disorders 10 Leukemia, Biphenotypic, Acute 10 Anemia, Refractory, with Excess of Blasts 9 Neoplasm, Residual 7 Leukemia, Myelomonocytic, Chronic 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Promyelocytic, Acute 6 Leukemia, Eosinophilic, Acute 6 Leukemia, Basophilic, Acute 6 Dendritic Cell Sarcoma, Interdigitating 5 Recurrence 4 Thrombocytopenia 3 Neutropenia 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Non-Hodgkin 3 Hematologic Neoplasms 3 Thrombocythemia, Essential 2 Sarcoma, Myeloid 2 Sarcoma, Kaposi 2

Interventions

Radiotherapy 7 Cisplatin 6 Radiation 4 Injections 4 Fibroblast Growth Factor 7 4 angiotensin I (1-7) 3 Propolis 3 Morphine 3 Low-Level Light Therapy 3 Drug Therapy 3 aluminum hydroxide, magnesium hydroxide, drug combination 2 Xylitol 2 Water 2 Radiotherapy, Intensity-Modulated 2 RRx-001 2 Probiotics 2 Pentoxifylline 2 Mouthwashes 2 Methotrexate 2 Melphalan 2 Lidocaine 2 Leucovorin 2 Interleukin 1 Receptor Antagonist Protein 2 Honey 2 Gabapentin 2 Fluorouracil 2 Diphenhydramine 2 Cryotherapy 2 Amifostine 2 tempol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡